Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 9Genitourinary 8Head & Neck 7Thoracic 4Lymphoid 4Other hematologic neoplasm 3Gynecologic 3Breast 3Plasma cell 2Dermatologic 2CNS 2Other solid neoplasm 1Other neoplasm 1Other 1Endocrine 1

Conditions

Prostatic Neoplasms 1Precancerous Conditions 1

Interventions

Cyclophosphamide 7fludarabine phosphate 6Peripheral Blood Stem Cell Transplantation 6Whole-Body Irradiation 5Tacrolimus 4Mycophenolic Acid 4Methotrexate 4Melphalan 4Busulfan 4Sulindac 3Paclitaxel 3Cyclosporine 3Cisplatin 3Capecitabine 3Biopsy 3Antilymphocyte Serum 3toripalimab 2sintilimab 2fludarabine 2Taxes 2Surveys and Questionnaires 2Specimen Handling 2Sirolimus 2Radiotherapy 2Patient Reported Outcome Measures 2Nivolumab 2Mesna 2Magnetic Resonance Spectroscopy 2Hyperthermic Intraperitoneal Chemotherapy 2Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Observation × Other neoplasm × Clear all
NCT00118066 2015-05-27

Calcitriol in Preventing Prostate Cancer in Patients With Prostatic Intraepithelial Neoplasia

Rutgers, The State University of New Jersey

Phase 2 Terminated
12 enrolled
GenitourinaryOther neoplasm

Precancerous Conditions, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡